Literature DB >> 18619424

Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.

Michael S Smirnov1, Eugene A Kiyatkin.   

Abstract

Marijuana smoking dramatically alters responses to various environmental stimuli. To study this phenomenon, we assessed how delta-9-tetrahydrocannabinol (THC), a primary psychoactive ingredient of marijuana, affects locomotor and brain (nucleus accumbens or NAcc), muscle and skin temperature responses to natural arousing stimuli (one-minute tail-pinch and one-minute social interaction with another male rat) and iv cocaine (1 mg/kg) in male rats. THC was administered at three widely varying doses (0.5, 2.0 and 8.0 mg/kg, ip), and the drug-induced changes in basal values and responses to stimuli were compared to those occurring following ip vehicle injections (control). Each stimulus in control conditions caused acute locomotor activation, a prolonged increase in brain and muscle temperature (0.6-1.0 degrees C for 20-50 min) and transient decrease in skin temperature (-0.6 degrees C for 1-3 min). While THC at any dose had a tendency to decrease spontaneous locomotion as well as brain and muscle temperatures, true hypothermia and hypoactivity as well as clearly diminished locomotor and temperature responses to all stimuli were only seen following the largest dose. In this case, temperature decreases in the NAcc were stronger than in the muscle, suggesting metabolic brain inhibition as the primary cause of hypoactivity, hypothermia and hyporesponsiveness. While weaker in strength and without associated vasodilatation, this response pattern is mimicked by general anesthetics, questioning to what extent the hypothermic action of THC is specific (i.e., mediated via endogenous cannabinoid receptors) or non-specific, reflecting drug interaction with membrane lipids or other receptors. In contrast, weaker behavioral and temperature effects of THC at lower doses resemble those of diazepam, whose locomotion- and temperature-decreasing effects are evident only in activated conditions, when rats are moving and basal temperatures are elevated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619424      PMCID: PMC2613277          DOI: 10.1016/j.brainres.2008.06.069

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

1.  Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats.

Authors:  F Nava; G Carta; G L Gessa
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

2.  The solubilizing detergents, Tween 80 and Triton X-100 non-competitively inhibit alpha 7-nicotinic acetylcholine receptor function in Xenopus oocytes.

Authors:  Murat Oz; Charles E Spivak; Carl R Lupica
Journal:  J Neurosci Methods       Date:  2004-08-30       Impact factor: 2.390

3.  Behavioral and brain temperature responses to salient environmental stimuli and intravenous cocaine in rats: effects of diazepam.

Authors:  Eugene A Kiyatkin; David Bae
Journal:  Psychopharmacology (Berl)       Date:  2007-10-16       Impact factor: 4.530

4.  Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.

Authors:  M D Adams; J T Earnhardt; W L Dewey; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1976-03       Impact factor: 4.030

5.  Variability of skin temperature in the waking monkey.

Authors:  M A Baker; M J Cronin; D G Mountjoy
Journal:  Am J Physiol       Date:  1976-02

Review 6.  General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.

Authors:  H F Hardman; E F Domino; M H Seevers
Journal:  Pharmacol Rev       Date:  1971-12       Impact factor: 25.468

7.  Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.

Authors:  H Valerie Curran; Catherine Brignell; Sally Fletcher; Paul Middleton; John Henry
Journal:  Psychopharmacology (Berl)       Date:  2002-07-23       Impact factor: 4.530

Review 8.  Do fever and anapyrexia exist? Analysis of set point-based definitions.

Authors:  Andrej A Romanovsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-10       Impact factor: 3.619

9.  1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse.

Authors:  D Holtzman; R A Lovell; J H Jaffe; D X Freedman
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

10.  State-dependent action of cocaine on brain temperature and movement activity: implications for movement sensitization.

Authors:  Yotam Blech-Hermoni; Eugene A Kiyatkin
Journal:  Pharmacol Biochem Behav       Date:  2004-04       Impact factor: 3.533

View more
  18 in total

1.  Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood.

Authors:  Lauren C Kruse; Jessica K Cao; Katie Viray; Nephi Stella; Jeremy J Clark
Journal:  Neuropsychopharmacology       Date:  2019-04-10       Impact factor: 7.853

Review 2.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

Review 3.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

4.  Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury.

Authors:  Jérémie Joffre; Che-Chung Yeh; Erika Wong; Mayuri Thete; Fengyun Xu; Ivana Zlatanova; Elliot Lloyd; Lester Kobzik; Matthieu Legrand; Judith Hellman
Journal:  J Immunol       Date:  2020-05-08       Impact factor: 5.422

Review 5.  Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.

Authors:  Douglas L Boggs; Jacques D Nguyen; Daralyn Morgenson; Michael A Taffe; Mohini Ranganathan
Journal:  Neuropsychopharmacology       Date:  2017-09-06       Impact factor: 7.853

6.  Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.

Authors:  M A Taffe
Journal:  Neuroscience       Date:  2011-11-29       Impact factor: 3.590

7.  Δ⁹Tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques.

Authors:  Michael A Taffe
Journal:  J Psychopharmacol       Date:  2012-04-22       Impact factor: 4.153

8.  The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.

Authors:  Samuel D Banister; Shane M Wilkinson; Mitchell Longworth; Jordyn Stuart; Nadine Apetz; Katrina English; Lance Brooker; Catrin Goebel; David E Hibbs; Michelle Glass; Mark Connor; Iain S McGregor; Michael Kassiou
Journal:  ACS Chem Neurosci       Date:  2013-04-17       Impact factor: 4.418

9.  Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).

Authors:  M Sałaga; A Mokrowiecka; P K Zakrzewski; A Cygankiewicz; E Leishman; M Sobczak; H Zatorski; E Małecka-Panas; R Kordek; M Storr; W M Krajewska; H B Bradshaw; J Fichna
Journal:  J Crohns Colitis       Date:  2014-02-14       Impact factor: 9.071

10.  Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences.

Authors:  Alexander Wong; Kirily Keats; Kieron Rooney; Callum Hicks; David J Allsop; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.